Metraipolis › archive › dc_1ecc495c01e5

Real-World Effectiveness of Cisplatin, 5-Fluorouracil, and Pembrolizumab Combination Therapy for Unresectable or Recurrent Esophageal Cancer — Europe PMC PMID:41097729

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41097729
DOI: 10.3390/cancers17193202
License (as archived): solo-consultazione
Archived: 2026-11-09T15:36:16.732Z
SHA-256 of the archived text: fa8deebf932e310d6fc25d25ff44bf1de3f490568229479f049ec250aed6a9bc
Stable URL of this page: https://metraipolis.com/documento/dc_1ecc495c01e5

How to cite

Real-World Effectiveness of Cisplatin, 5-Fluorouracil, and Pembrolizumab Combination Therapy for Unresectable or Recurrent Esophageal Cancer — Europe PMC PMID:41097729 — Europe PMC (en), https://europepmc.org/article/MED/41097729 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_1ecc495c01e5 (Metraipolis archive dc_1ecc495c01e5, sha256 fa8deebf932e310d6fc25d25ff44bf1de3f490568229479f049ec250aed6a9bc)

BibTeX

@misc{dc1ecc495c01e5,
  title = {Real-World Effectiveness of Cisplatin, 5-Fluorouracil, and Pembrolizumab Combination Therapy for Unresectable or Recurrent Esophageal Cancer — Europe PMC PMID:41097729},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41097729},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_1ecc495c01e5; sha256 fa8deebf932e310d6fc25d25ff44bf1de3f490568229479f049ec250aed6a9bc},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41097729. Agents can read the archived copy with the MCP tool read_document.